Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2008 (2008), Article ID 614852, 5 pages
http://dx.doi.org/10.1155/2008/614852
Review Article

Regulation of Cell Proliferation and Differentiation by PPAR

Institute of Molecular Biology and Tumor Research (IMT), Philipps-University, Emil-Mannkopff-Strasse 2, 35032 Marburg, Germany

Received 23 July 2008; Accepted 13 August 2008

Academic Editor: Francine M. Gregoire

Copyright © 2008 Rolf Müller et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Molnár, M. Matilainen, and C. Carlberg, “Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators,” The Journal of Biological Chemistry, vol. 280, no. 28, pp. 26543–26556, 2005. View at Publisher · View at Google Scholar
  2. L. Michalik, J. Auwerx, J. P. Berger et al., “International union of pharmacology. LXI. Peroxisome proliferator-activated receptors,” Pharmacological Reviews, vol. 58, no. 4, pp. 726–741, 2006. View at Publisher · View at Google Scholar
  3. B. Desvergne, L. Michalik, and W. Wahli, “Transcriptional regulation of metabolism,” Physiological Reviews, vol. 86, no. 2, pp. 465–514, 2006. View at Publisher · View at Google Scholar
  4. R. Kostadinova, W. Wahli, and L. Michalik, “PPARs in diseases: control mechanisms of inflammation,” Current Medicinal Chemistry, vol. 12, no. 25, pp. 2995–3009, 2005. View at Publisher · View at Google Scholar
  5. K. S. Kilgore and A. N. Billin, “PPARβ/δ ligands as modulators of the inflammatory response,” Current Opinion in Investigational Drugs, vol. 9, no. 5, pp. 463–469, 2008. View at Google Scholar
  6. M. A. Peraza, A. D. Burdick, H. E. Marin, F. J. Gonzalez, and J. M. Peters, “The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR),” Toxicological Sciences, vol. 90, no. 2, pp. 269–295, 2006. View at Publisher · View at Google Scholar
  7. J. M. Peters, S. S. T. Lee, W. Li et al., “Growths, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor ß(d),” Molecular and Cellular Biology, vol. 20, no. 14, pp. 5119–5128, 2000. View at Publisher · View at Google Scholar
  8. L. Michalik, B. Desvergne, N. S. Tan et al., “Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)a and PPARß mutant mice,” The Journal of Cell Biology, vol. 154, no. 4, pp. 799–814, 2001. View at Publisher · View at Google Scholar
  9. Y. Barak, D. Liao, W. He et al., “Effects of peroxisome proliferator-activated receptor d on placentation, adiposity, and colorectal cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 303–308, 2002. View at Publisher · View at Google Scholar
  10. K. Nadra, S. I. Anghel, E. Joye et al., “Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor ß/d,” Molecular and Cellular Biology, vol. 26, no. 8, pp. 3266–3281, 2006. View at Publisher · View at Google Scholar
  11. N. Di-Po, N. S. Tan, L. Michalik, W. Wahli, and B. Desvergne, “Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway,” Molecular Cell, vol. 10, no. 4, pp. 721–733, 2002. View at Publisher · View at Google Scholar
  12. M. Westergaard, J. Henningsen, M. L. Svendsen et al., “Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid,” Journal of Investigative Dermatology, vol. 116, no. 5, pp. 702–712, 2001. View at Publisher · View at Google Scholar
  13. M. Schmuth, C. M. Haqq, W. J. Cairns et al., “Peroxisome proliferator-activated receptor (PPAR)-ß/d stimulates differentiation and lipid accumulation in keratinocytes,” Journal of Investigative Dermatology, vol. 122, no. 4, pp. 971–983, 2004. View at Publisher · View at Google Scholar
  14. D. J. Kim, I. A. Murray, A. M. Burns, F. J. Gonzalez, G. H. Perdew, and J. M. Peters, “Peroxisome proliferator-activated receptor-β/δ inhibits epidermal cell proliferation by down-regulation of kinase activity,” The Journal of Biological Chemistry, vol. 280, no. 10, pp. 9519–9527, 2005. View at Publisher · View at Google Scholar
  15. A. D. Burdick, D. J. Kim, M. A. Peraza, F. J. Gonzalez, and J. M. Peters, “The role of peroxisome proliferator-activated receptor-β/δ in epithelial cell growth and differentiation,” Cellular Signalling, vol. 18, no. 1, pp. 9–20, 2006. View at Publisher · View at Google Scholar
  16. D. J. Kim, M. T. Bility, A. N. Billin, T. M. Willson, F. J. Gonzalez, and J. M. Peters, “PPARβ/δ selectively induces differentiation and inhibits cell proliferation,” Cell Death & Differentiation, vol. 13, no. 1, pp. 53–60, 2006. View at Publisher · View at Google Scholar
  17. A. D. Burdick, M. T. Bility, E. E. Girroir et al., “Ligand activation of peroxisome proliferator-activated receptor-ß/d(PPARß/d) inhibits cell growth of human N/TERT-1 keratinocytes,” Cellular Signalling, vol. 19, no. 6, pp. 1163–1171, 2007. View at Publisher · View at Google Scholar
  18. M.-Q. Man, G. D. Barish, M. Schmuth et al., “Deficiency of PPARß/d in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation,” Journal of Investigative Dermatology, vol. 128, no. 2, pp. 370–377, 2008. View at Publisher · View at Google Scholar
  19. M. Romanowska, N. al Yacoub, H. Seidel et al., “PPARd enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor,” Journal of Investigative Dermatology, vol. 128, no. 1, pp. 110–124, 2008. View at Publisher · View at Google Scholar
  20. C. Bastie, S. Luquet, D. Holst, C. Jehl-Pietri, and P. A. Grimaldi, “Alterations of peroxisome proliferator-activated receptor δ activity affect fatty acid-controlled adipose differentiation,” The Journal of Biological Chemistry, vol. 275, no. 49, pp. 38768–38773, 2000. View at Publisher · View at Google Scholar
  21. J. B. Hansen, H. Zhang, T. H. Rasmussen, R. K. Petersen, E. N. Flindt, and K. Kristiansen, “Peroxisome proliferator-activated receptor δ (PPARδ)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling,” The Journal of Biological Chemistry, vol. 276, no. 5, pp. 3175–3182, 2001. View at Publisher · View at Google Scholar
  22. K. Matsusue, J. M. Peters, and F. J. Gonzalez, “PPARβ/δ potentiates PPARγ-stimulated adipocyte differentiation,” The FASEB Journal, vol. 18, no. 12, pp. 1477–1479, 2004. View at Publisher · View at Google Scholar
  23. Y. Barak, Y. Sadovsky, and T. Shalom-Barak, “PPAR signaling in placental development and function,” PPAR Research, vol. 2008, Article ID 142082, 11 pages, 2008. View at Publisher · View at Google Scholar
  24. F. Varnat, B. B. Heggeler, P. Grisel et al., “PPARß/d regulates paneth cell differentiation via controlling the Hedgehog signaling pathway,” Gastroenterology, vol. 131, no. 2, pp. 538–553, 2006. View at Publisher · View at Google Scholar
  25. K. Hellemans, L. Michalik, A. Dittie et al., “Peroxisome proliferator-activated receptor-ß signaling contributes to enhanced proliferation of hepatic stellate cells,” Gastroenterology, vol. 124, no. 1, pp. 184–201, 2003. View at Publisher · View at Google Scholar
  26. I. Saluja, J. G. Granneman, and R. P. Skoff, “PPAR δ agonists stimulate oligodendrocyte differentiation in tissue culture,” GLIA, vol. 33, no. 3, pp. 191–204, 2001. View at Publisher · View at Google Scholar
  27. B. E. J. Teunissen, P. J. H. Smeets, P. H. M. Willemsen, L. J. De Windt, G. J. Van der Vusse, and M. Van Bilsen, “Activation of PPARδ inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts,” Cardiovascular Research, vol. 75, no. 3, pp. 519–529, 2007. View at Publisher · View at Google Scholar
  28. J. Adamkiewicz, K. Kaddatz, M. Rieck, B. Wilke, S. Müller-Brüsselbach, and R. Müller, “Proteomic profile of mouse fibroblasts with a targeted disruption of the peroxisome proliferator activated receptor-β/δ gene,” Proteomics, vol. 7, no. 8, pp. 1208–1216, 2007. View at Publisher · View at Google Scholar
  29. S. Müller-Brüsselbach, M. Kömhoff, M. Rieck et al., “Deregulation of tumor angiogenesis and blockade of tumor growth in PPARß-deficient mice,” The EMBO Journal, vol. 26, no. 15, pp. 3686–3698, 2007. View at Publisher · View at Google Scholar
  30. H.-J. Lim, S. Lee, J.-H. Park et al., “PPARd agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle,” Atherosclerosis. In press. View at Publisher · View at Google Scholar
  31. L. Piqueras, A. R. Reynolds, K. M. Hodivala-Dilke et al., “Activation of PPARß/d induces endothelial cell proliferation and angiogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 63–69, 2007. View at Publisher · View at Google Scholar
  32. E. E. Girroir, H. E. Hollingshead, A. N. Billin et al., “Peroxisome proliferator-activated receptor-ß/d (PPARß/d) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines,” Toxicology, vol. 243, no. 1-2, pp. 236–243, 2008. View at Publisher · View at Google Scholar
  33. H. E. Hollingshead, R. L. Killins, M. G. Borland et al., “Peroxisome proliferator-activated receptor-ß/d (PPARß/d) ligands do not potentiate growth of human cancer cell lines,” Carcinogenesis, vol. 28, no. 12, pp. 2641–2649, 2007. View at Publisher · View at Google Scholar
  34. L. Yang, Z.-G. Zhou, X.-L. Zheng et al., “RNA interference against peroxisome proliferator-activated receptor d gene promotes proliferation of human colorectal cancer cells,” Diseases of the Colon & Rectum, vol. 51, no. 3, pp. 318–328, 2008. View at Publisher · View at Google Scholar
  35. S. Di Loreto, B. D'Angelo, M. A. D'Amico et al., “PPARß agonists trigger neuronal differentiation in the human neuroblastoma cell line SH-SY5Y,” Journal of Cellular Physiology, vol. 211, no. 3, pp. 837–847, 2007. View at Publisher · View at Google Scholar
  36. S. W. Han, J. D. Ritzenthaler, Y. Zheng, and J. Roman, “PPARβ/δ agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3-K and NF-κB signals,” American Journal of Physiology, vol. 294, no. 6, pp. L1238–L1249, 2008. View at Publisher · View at Google Scholar
  37. K. Fukumoto, Y. Yano, N. Virgona et al., “Peroxisome proliferator-activated receptor d as a molecular target to regulate lung cancer cell growth,” FEBS Letters, vol. 579, no. 17, pp. 3829–3836, 2005. View at Publisher · View at Google Scholar
  38. D. J. Kim, T. E. Akiyama, F. S. Harman et al., “Peroxisome proliferator-activated receptor ß(d)-dependent regulation of ubiquatin C expression contributes to attenuation of skin carcinogenesis,” The Journal of Biological Chemistry, vol. 279, no. 22, pp. 23719–23727, 2004. View at Publisher · View at Google Scholar
  39. A. K. Indra, E. Castaneda, M. C. Antal et al., “Malignant transformation of DMBA/TPA-induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor a in epidermal keratinocytes,” Journal of Investigative Dermatology, vol. 127, no. 5, pp. 1250–1260, 2007. View at Publisher · View at Google Scholar
  40. S. Müller-Brüsselbach, S. Ebrahimsade, J. Jäkel et al., “Growth of transgenic RAF-induced lung adenomas is increased in mice with a disrupted PPARß/d gene,” International Journal of Oncology, vol. 31, no. 3, pp. 607–611, 2007. View at Google Scholar
  41. G. G. Mackenzie, S. Rasheed, W. Wertheim, and B. Rigas, “NO-donating NSAIDs, PPARδ, and cancer: does PPARδ contribute to colon carcinogenesis?” PPAR Research, vol. 2008, Article ID 919572, 11 pages, 2008. View at Publisher · View at Google Scholar
  42. F. S. Harman, C. J. Nicol, H. E. Marin, J. M. Ward, F. J. Gonzalez, and J. M. Peters, “Peroxisome proliferator-activated receptor-δ attenuates colon carcinogenesis,” Nature Medicine, vol. 10, no. 5, pp. 481–483, 2004. View at Publisher · View at Google Scholar
  43. K. R. Reed, O. J. Sansom, A. J. Hayes et al., “PPARd status and Apc-mediated tumourigenesis in the mouse intestine,” Oncogene, vol. 23, no. 55, pp. 8992–8996, 2004. View at Publisher · View at Google Scholar
  44. H. E. Marin, M. A. Peraza, A. N. Billin et al., “Ligand activation of peroxisome proliferator-activated receptor ß inhibits colon carcinogenesis,” Cancer Research, vol. 66, no. 8, pp. 4394–4401, 2006. View at Publisher · View at Google Scholar
  45. H. E. Hollingshead, M. G. Borland, A. N. Billin, T. M. Willson, F. J. Gonzalez, and J. M. Peters, “Ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms,” Carcinogenesis, vol. 29, no. 1, pp. 169–176, 2008. View at Publisher · View at Google Scholar
  46. R. A. Gupta, D. Wang, S. Katkuri, H. Wang, S. K. Dey, and R. N. DuBois, “Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-δ accelerates intestinal adenoma growth,” Nature Medicine, vol. 10, no. 3, pp. 245–247, 2004. View at Publisher · View at Google Scholar
  47. D. Wang, H. Wang, Q. Shi et al., “Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor d,” Cancer Cell, vol. 6, no. 3, pp. 285–295, 2004. View at Publisher · View at Google Scholar
  48. D. Wang, H. Wang, Y. Guo et al., “Crosstalk between peroxisome proliferator-activated receptor d and VEGF stimulates cancer progression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 50, pp. 19069–19074, 2006. View at Publisher · View at Google Scholar
  49. J. M. Peters, H. E. Hollingshead, and F. J. Gonzalez, “Role of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and disease,” Clinical Sciences, vol. 115, no. 4, pp. 107–127, 2008. View at Publisher · View at Google Scholar
  50. M. J. Bissell and D. Radisky, “Putting tumours in context,” Nature Reviews Cancer, vol. 1, no. 1, pp. 46–54, 2001. View at Publisher · View at Google Scholar
  51. A. Abdollahi, C. Schwager, J. Kleeff et al., “Transcriptional network governing the angiogenic switch in human pancreatic cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 31, pp. 12890–12895, 2007. View at Publisher · View at Google Scholar
  52. L. C. Armstrong and P. Bornstein, “Thrombospondins 1 and 2 function as inhibitors of angiogenesis,” Matrix Biology, vol. 22, no. 1, pp. 63–71, 2003. View at Publisher · View at Google Scholar
  53. M. H. Lee, I. Reynisdóttir, and J. Massagué, “Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution,” Genes & Development, vol. 9, no. 6, pp. 639–649, 1995. View at Publisher · View at Google Scholar
  54. C.-H. Lee, A. Chawla, N. Urbiztondo, D. Liao, W. A. Boisvert, and R. M. Evans, “Transcriptional repression of atherogenic inflammation: modulation by PPARδ,” Science, vol. 302, no. 5644, pp. 453–457, 2003. View at Publisher · View at Google Scholar
  55. M. Heinäniemi, J. O. Uski, T. Degenhardt, and C. Carlberg, “Meta-analysis of primary target genes of peroxisome proliferator-activated receptors,” Genome Biology, vol. 8, no. 7, article R147, 2007. View at Publisher · View at Google Scholar